Description

Description

Evopride Plus (2mg/500mg) is a fixed-dose combination medicine manufactured by PharmaEvo, formulated with Glimepiride 2mg and Metformin 500mg in each tablet. This pack contains 30 tablets and represents a higher-strength Glimepiride variant within the Evopride Plus range, intended for adults with type 2 diabetes mellitus who need a stronger insulin-stimulating effect alongside the standard Metformin dose. This strength is typically prescribed for patients who have already tolerated the 1mg Glimepiride combination but require further improvement in blood sugar control, or for those whose physician determines that a higher Glimepiride dose is appropriate based on individual glycemic targets. Glimepiride works by stimulating the pancreas to release more insulin, while Metformin complements this by reducing glucose production in the liver and improving the body’s sensitivity to insulin. Together, this combination is intended to offer more comprehensive glycemic support for patients who need a stronger dual-action approach. Evopride Plus should always be used as part of a broader diabetes management plan that includes appropriate diet, physical activity, and regular blood sugar monitoring, under the ongoing supervision of a qualified healthcare provider.

Ingredients

Each tablet of Evopride Plus (2/500mg) contains two active pharmaceutical ingredients: Glimepiride 2mg, a sulfonylurea that stimulates insulin release from the pancreas at a higher strength than the base combination dose, and Metformin Hydrochloride 500mg, a biguanide-class antidiabetic agent that reduces hepatic glucose output and enhances insulin sensitivity. The tablet also contains standard pharmaceutical excipients, including binders and film-coating agents, which support the tablet’s structural stability and consistent release of both active ingredients.

Dosage Form

Evopride Plus (2/500mg) is available as an oral film-coated tablet, with each tablet delivering a combined strength of 2mg Glimepiride and 500mg Metformin. The pack contains 30 tablets, suited to patients requiring a stronger Glimepiride component within their combination therapy, as determined by a physician.

Uses

Evopride Plus (2/500mg) is used to help improve blood sugar control in adults with type 2 diabetes mellitus who require a higher dose of Glimepiride in combination with Metformin. It is often prescribed for patients who need further glycemic improvement beyond what the 1mg strength provides, or for those whose blood sugar levels warrant a stronger combination approach from the outset. It may also be used alongside other antidiabetic medicines as part of a broader treatment strategy. This medicine is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

How to Use

Evopride Plus tablets are typically taken once or twice daily with meals, as directed by a doctor, to help reduce gastrointestinal discomfort associated with Metformin and to align the Glimepiride component with food intake, minimizing the risk of low blood sugar. Tablets should be swallowed whole with a glass of water and should not be crushed, split, or chewed unless specifically advised. Dosage and treatment duration should strictly follow the physician’s prescription, as these are individualized based on factors such as kidney function, current blood sugar levels, and other medications in use. Meals should not be skipped after taking this medicine. If a dose is missed, it should generally be skipped rather than doubled, and the next dose should be taken at the regular scheduled time, following the doctor’s specific guidance.

Side Effects

Evopride Plus (2/500mg) may cause side effects in some individuals, and the higher Glimepiride strength may increase the likelihood of low blood sugar for some patients. Commonly reported effects include hypoglycemia, with symptoms such as shakiness, sweating, dizziness, confusion, or hunger, along with gastrointestinal symptoms such as nausea, diarrhea, and stomach discomfort, particularly when treatment is first started. Some patients may also notice headache or a metallic taste in the mouth. In rare cases, more serious effects such as lactic acidosis (linked to Metformin) or severe allergic reactions may occur, requiring immediate medical attention if symptoms such as severe abdominal pain, unusual tiredness, rapid breathing, or persistent vomiting appear.

Pregnancy & Breastfeeding

Evopride Plus (2/500mg) is generally not recommended for use during pregnancy. Sulfonylureas like Glimepiride may pose risks to the developing baby, and insulin is typically preferred for blood sugar management during pregnancy, particularly at higher Glimepiride strengths. Women who are pregnant, planning pregnancy, or suspect they may be pregnant should inform their doctor without delay so that alternative treatment can be arranged. The safety of this combination during breastfeeding has not been well established, and alternative diabetes management options are generally considered for nursing mothers. Any decision regarding use during pregnancy or breastfeeding should be made only in consultation with a qualified healthcare provider.

Storage Instructions

Evopride Plus tablets should be stored at room temperature in a cool, dry place, protected from direct sunlight, heat, and excess moisture. Tablets should remain in their original packaging until use to guard against environmental exposure. Keep the medicine out of reach of children and pets, and avoid using it beyond the expiry date printed on the pack. Any unused or expired tablets should be disposed of responsibly in line with local pharmaceutical disposal guidelines, rather than being thrown away with regular household waste.

FAQs

How is the 2mg Glimepiride strength different from the 1mg version?
The 2mg strength offers a stronger insulin-stimulating effect, typically used once a patient has been stabilized on a lower dose and requires further blood sugar improvement.

What should I do if I experience symptoms of low blood sugar?
You should consume a fast-acting source of sugar, such as juice or glucose tablets, and inform your doctor if this occurs, as your dosage may need reassessment.

Should this medicine be taken with food?
Yes, taking it with meals is generally recommended to help minimize gastrointestinal discomfort and reduce the risk of low blood sugar from the Glimepiride component.

Is regular monitoring required while taking this medicine?
Yes, periodic monitoring of blood sugar levels and kidney function is generally recommended for patients on this combination therapy, as advised by their healthcare provider.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.